sunspotter
11 hours ago
" I appreciate all of you and all the information you have shared over the years here while the company has gone through this mess."
Yes, all this "information" has helped make fortunes.
Unfortunately those fortunes were made by the crooks behind this, such as Barnhill and his paid touts like Terry Hallinan.
Retail shareholders on the other hand have been taken to the cleaners by absorbing all the "information" that's been "shared" here.
College funds, retirements, marriages etc all ruined, but apparently the future is still bright.
chazzy1
1 day ago
Those are some good questions, JackNapier, questions that most of us have. Since our new CEO, Dr. Alan Faust, has taken the helm, there have been no public announcements, PRs, or SEC filings (except for an 8k to announce his hiring), and the stock remains on the Expert Market where it is not tradeable to retail investors.
Dr. Faust has created a new website for HDC which includes his contact information. I would suggest that you reach out to him with your questions and, if you get a reply, please share that information with us.
I do believe that Dr. Faust represents the best hope for HDVY shareholders to see a return on this investment. Good luck!
chazzy1
5 days ago
Good points, Alan, and thank you for bringing your unique perspective to bear on HDC's algorithms.
According to the USPTO, HDC owns the "exclusive rights to all" SVM-RFE technology, so I am not exactly sure if you are referring to new algorithms that fall outside of SVM-RFE, or something else (when you state that there sre much better algorithms out there).
HDC has hired one of the foremost experts in the field, with a proven track record in business development, to monetize HDC's IP.
I would think that, when he took this job, he was astutely aware of the state of the art of this kind of technology, and saw a pathway to monetization.
Who can say, at this point, just what pathway Dr. Faust had in mind?
It is possible that he could be in collaboration with one or more medical diagnostics companies to develop new tests using HDC's proprietary technology.
If so, there would likely be no public announcement until such product has gone through the required testing and approval process. JMHO.
LocWolf
4 weeks ago
Ou71764
Friday, February 07, 2025 5:38:30 PM
Post# of 18725
I did get a response to my email to Alan - it directed me to the new website, but he didn't sign the response. So nothing specific was added. From the email to me: "Here, youβll find an update on our mission and goals as we continue to execute our strategic plans."
I'm encouraged to see "something" is happening. But I didn't see anything on the website about getting listed, or that we were once a publicly traded company. I hope that shareholders are still part of the plan.
https://healthdiscoverycorporation.com/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175778613
LocWolf
1 month ago
Now don't cut this in stone as I have been wrong so many time it taint funny but.............
The patent of interest 11,105,808 B2 was continued from an application and possibly (as I see it) patent 9,952,221B2.
Within the above the U.S. Patent No. 9,952,221 "Methods for Screening, Predicting and Monitoring Prostate Cancer" should expire on 01/24/2022. Also the U.S. Patent Publication No. 2018/0321245 Methods for Screening, Predicting and Monitoring Prostate Cancer should expire on 01/24/2022.
It appears to me that patent 11,105,808 B2 might be a continuation but has it expired? It was extended 394 days but was that from 8/31/21 or what?
I see a clear difference in the two patents claim wise and writing clarity/skills. Could Guyon modify the newest patents or perhaps it is being developed as we wait or is the Locwolf howling & scratching at the cage walls.
Hey! I gotta be entertaining once in a while.